Guan Tao, Li Ji-Cheng, Li Min-Ju, Tou Jin-Fa
Department of Lymphology, Institute of Cell Biology, Zhejiang University Medical College, Hangzhou 310031, Zhejiang Province, China.
World J Gastroenterol. 2005 Jan 14;11(2):275-9. doi: 10.3748/wjg.v11.i2.275.
To investigate the relationship between mutations of rearranged during transfection (RET) proto-oncogene and Chinese patients with Hirschsprung's disease (HD), and to elucidate the genetic mechanism of familial HD patient at the molecular level.
Genomic DNA was extracted from venous blood of probands and their relatives in two genealogies. Polymerase chain reaction (PCR) products, which were amplified using specific primers (RET, exons 11, 13, 15 and 17), were electrophoresed to analyze the single-strand conformational polymorphism (SSCP) patterns. The positive amplified products were sequenced. Forty-eight sporadic HD patients and 30 normal children were screened for mutations of RET proto-oncogene simultaneously.
Three cases with HD in one family were found to have a G heterozygous insertion at nucleotide 18,974 in exon 13 of RET cDNA (18,974insG), which resulted in a frameshift mutation. In another family, a heterozygosity for T to G transition at nucleotide 18,888 in the same exon which resulted in a synonymous mutation of Leu at codon 745 was detected in the proband and his father. Eight RET mutations were confirmed in 48 sporadic HD patients.
Mutations of RET proto-oncogene may play an important role in the pathogenesis of Chinese patients with HD. Detection of mutated RET proto-oncogene carriers may be used for genetic counseling of potential risk for HD in the affected families.
研究转染期间重排(RET)原癌基因突变与中国先天性巨结肠病(HD)患者的关系,并在分子水平阐明家族性HD患者的遗传机制。
从两个家系的先证者及其亲属的静脉血中提取基因组DNA。使用特异性引物(RET,第11、13、15和17外显子)扩增的聚合酶链反应(PCR)产物进行电泳,以分析单链构象多态性(SSCP)模式。对阳性扩增产物进行测序。同时对48例散发性HD患者和30名正常儿童进行RET原癌基因突变筛查。
在一个家族中发现3例HD患者在RET cDNA第13外显子的核苷酸18974处有一个G杂合插入(18974insG),导致移码突变。在另一个家族中,先证者及其父亲在同一外显子的核苷酸18888处检测到T到G的杂合转变,导致密码子745处的Leu同义突变。在48例散发性HD患者中确认了8个RET突变。
RET原癌基因突变可能在中国HD患者的发病机制中起重要作用。检测RET原癌基因突变携带者可用于对受影响家庭中HD潜在风险进行遗传咨询。